Literature DB >> 19440819

Mediastinal lymph node carcinoma of an unknown primary site: clinicopathological examination.

Ken Miwa1, Shinji Fujioka, Yoshin Adachi, Tomohiro Haruki, Yuji Taniguchi, Hiroshige Nakamura.   

Abstract

PURPOSE: We examined the clinicopathological features of four mediastinal lymph node carcinomas from an unknown primary site.
METHODS: Four patients with mediastinal lymph node carcinoma from an unknown primary site were treated at our hospital during the past 6 years.
RESULTS: All of the patients were men, with an average age of 74.0 years (range 70-78 years). Histologically, one lesion was poorly differentiated adenocarcinoma, two were poorly differentiated squamous cell carcinoma, and one was undifferentiated carcinoma. Radical resection of the mediastinal tumor and radiotherapy were performed in two patients, both of whom were still alive with no evidence of recurrence at 44 and 82 months, respectively, after the operation. Thoracoscopic biopsy was performed in two patients, and both underwent chemoradiotherapy. These two patients were alive at 24 and 33 months, respectively, after the biopsies.
CONCLUSION: Radical resection of mediastinal lymph node carcinoma with an unknown primary site has the possibility of a good prognosis. In nonradical cases, it is important to perform a biopsy to make an accurate diagnosis and then administer radiotherapy and/or chemotherapy postoperatively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440819     DOI: 10.1007/s11748-008-0361-5

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  4 in total

1.  Metastatic cancer of unknown primary site.

Authors:  F F Holmes; T L Fouts
Journal:  Cancer       Date:  1970-10       Impact factor: 6.860

2.  Metastatic carcinomas from occult primary tumors. A study of 254 patients.

Authors:  M S Didolkar; N Fanous; E G Elias; R H Moore
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

3.  Metastatic cancer from an undetermined primary site.

Authors:  J A Greager; D Wood; T K Das Gupta
Journal:  J Surg Oncol       Date:  1983-06       Impact factor: 3.454

4.  Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.

Authors:  J F Stewart; M H Tattersall; R L Woods; R M Fox
Journal:  Br Med J       Date:  1979-06-09
  4 in total
  3 in total

1.  Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Authors:  Paul B Romesser; Yonatan Bardash; Darren Buonocore; Jamie E Chaft; James Huang; David R Jones; Andreas Rimner; Abraham J Wu
Journal:  Lung Cancer       Date:  2018-11-17       Impact factor: 5.705

2.  Relapsed cervicomediastinal lymph node carcinoma with an unknown primary site treated with TS-1 alone: a case report.

Authors:  Toshiki Yajima; Ryoichi Onozato; Yoshinori Shitara; Akira Mogi; Shigebumi Tanaka; Hiroyuki Kuwano
Journal:  BMC Res Notes       Date:  2013-12-27

3.  Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: a case report.

Authors:  Daichi Shikata; Takahiro Nakagomi; Rumi Higuchi; Yujiro Yokoyama; Toshio Oyama; Taichiro Goto
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.